Could a light cap ease autism symptoms in young children?

NCT ID NCT06359080

Completed Symptom relief Sponsor: JelikaLite LLC Source: ClinicalTrials.gov ↗

First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time

Summary

This trial tests whether a device called Cognilum, which shines light on the head (transcranial photobiomodulation), can reduce autism symptoms in children aged 2 to 7 with moderate to severe autism. Children wear the device for up to 15 minutes twice a week for 10 weeks. Researchers measure changes using a standard autism rating scale and brain activity recordings.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Cognilum device (transcranial photobiomodulation)
What this could lead to: If it works, this could offer a non-invasive, drug-free way to ease core autism symptoms in young children.
What could go wrong: This is a small early-stage trial with only 25 participants, so results may not apply broadly. The treatment is experimental and may not reduce symptoms.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AUTISM SPECTRUM DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

autism autism spectrum disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AUTISM SPECTRUM DISORDER

Contacts and locations

Show contact details

Locations

Dr. Steingold Psychology PC

Brooklyn, New York, 11229, United States
Dr. Steingold Psychology PC

New York, New York, 10019, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.